Modeling and docking the endothelin G-protein-coupled receptor

Area of Science:

• Structural Biology
• Computational Chemistry
• Pharmacology

Background:

• G-protein-coupled receptors (GPCRs) are crucial drug targets.
• The endothelin receptor type A (ET(A)) mediates important physiological processes.
• Understanding ET(A) receptor-ligand interactions is key for therapeutic development.

Purpose of the Study:

• To construct a detailed computational model of the endothelin receptor type A (ET(A)).
• To validate the model by predicting ligand-binding sites and comparing with experimental data.
• To provide a foundation for rational drug design targeting ET(A) receptors.

Main Methods:

• Segmented modeling approach using bovine rhodopsin as a template for transmembrane helices.
• NMR structures and homologous protein structures were used for loop and N-terminal regions.
• The FTDOCK algorithm was employed to predict ligand-binding sites for human endothelin.

Main Results:

• The constructed ET(A) receptor model successfully predicted the ligand-binding site for human endothelin.
• Predicted binding interactions align with existing mutational and biochemical data.
• The model correctly identified no tight binding sites for the inactive bigET precursor.

Conclusions:

• The validated ET(A) receptor model provides an accurate representation of the receptor structure.
• The model serves as a valuable tool for the rational design of novel ET(A) receptor agonists and antagonists.
• This work facilitates the development of new therapeutics modulating GPCR signaling pathways.